Through further investigations for the mechanisms underlying the enhanced sensitivity to HDAC inhibitors in UHRF1‐depleted cells, we found that UHRF1 downmodulation significantly decreases the expression of GSTA4 and TXN2 in RB cells. Here, HDAC9 is linked to retinoblastoma.